Galle Liz 4
4 · CVRx, Inc. · Filed Oct 18, 2023
Insider Transaction Report
Form 4
CVRx, Inc.CVRX
Galle Liz
VP of Global Clinical Research
Transactions
- Exercise/Conversion
Common Stock
2023-10-16$0.24/sh+778$184→ 778 total - Exercise/Conversion
Stock Option (right to buy)
2023-10-16−778→ 0 totalExercise: $0.24Exp: 2023-11-11→ Common Stock (778 underlying)
Footnotes (1)
- [F1]Fully vested.